macro

Manulife Financial Q3 adjusted EPS beats analyst forecasts

Manulife Financial reported adjusted EPS of C$1.24 for the quarter ended September 30, above the C$1.18 analyst average, according to Earnings Summary citing LSEG data.

the same feed is available to bots and dashboards through the api. connect the api →

what happened

Manulife Financial posted adjusted earnings of C$1.24 per share for the quarter ended September 30, up from C$1.16 a year earlier. The average estimate of 13 analysts was C$1.18, so the insurer came in ahead of expectations. Revenue reached C$10.95 billion and net income came to C$1.42 billion. On a reported basis, earnings per share were 82 cents. Figures come from an Earnings Summary report based on LSEG data.

why it matters

The shares rose 5.8% during the quarter and 28.8% so far this year. Meanwhile, the average earnings estimate fell about 1% over three months, and nine analysts cut their forecasts over the last 30 days. Recommendations remain mostly positive, with 10 buy ratings, 4 holds and 1 sell.

market impact

Manulife Financial shares: earnings above forecasts support the stock, though analyst estimates edged lower

  • Manulife Financial shares pressure up — earnings above the consensus forecast support the stock

tags

instruments

Manulife FinancialMFCTSX financials

sources

  1. Manulife Financial Corporation reports results for the quarter ended September 30 — Earnings Summary, 5 November 2026 at 09:49 UTC
  2. TOYOTA MOTOR CORPORATION reports results for the quarter ended September 30 — Earnings Summary, 5 November 2026 at 10:04 UTC
  3. TOYOTA MOTOR CORPORATION reports results for the quarter ended September 30 — Earnings Summary, 5 November 2026 at 10:25 UTC
  4. ArcelorMittal SA reports results for the quarter ended September 30 — Earnings Summary, 5 November 2026 at 10:36 UTC
  5. Haemonetics Corp reports results for the quarter ended September 30 — Earnings Summary, 5 November 2026 at 14:09 UTC
  6. PENN Entertainment, Inc. reports results for the quarter ended September 30 — Earnings Summary, 5 November 2026 at 14:16 UTC
  7. Southern Co reports results for the quarter ended September 30 — Earnings Summary, 5 November 2026 at 14:19 UTC
  8. Iovance Biotherapeutics Inc reports results for the quarter ended September 30 — Earnings Summary, 5 November 2026 at 14:32 UTC

prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.

alerts on your topics, the morning digest and the api — in your account.

get stories in real time ↗